Edition:
United States

Aradigm Corp (ARDM.OQ)

ARDM.OQ on NASDAQ Stock Exchange Capital Market

1.11USD
3:59pm EST
Change (% chg)

$0.04 (+3.74%)
Prev Close
$1.07
Open
$1.09
Day's High
$1.15
Day's Low
$1.07
Volume
3,344
Avg. Vol
6,294
52-wk High
$7.26
52-wk Low
$1.00

Chart for

About

Aradigm Corporation is a pharmaceutical company focused on the development and commercialization of products for the treatment and prevention of severe respiratory diseases. The Company's lead product candidate is Pulmaquin inhaled ciprofloxacin, which is in Phase III clinical trials. It offers AERx pulmonary drug delivery... (more)
No analyst recommendations are available for .

Overall

Beta: 9.33
Market Cap(Mil.): $16.27
Shares Outstanding(Mil.): 15.20
Dividend: --
Yield (%): --

Financials

  ARDM.OQ Industry Sector
P/E (TTM): -- 81.01 29.57
EPS (TTM): -1.11 -- --
ROI: -375.23 -0.53 12.77
ROE: -- -3.22 14.47

BRIEF-Aradigm Q1 Loss Per Share $0.32

* Q1 REVENUE $1.5 MILLION VERSUS $1.7 MILLION Source text for Eikon: Further company coverage:

May 15 2018

Earnings vs. Estimates